Election Impact: Key House Committees
Executive Summary
Following the Nov. 8 election, many members of the House Ways and Means Committee, which has jurisdiction over Medicare and taxes, and the House Energy and Commerce, which oversees FDA and other health matters, kept their seats. A handful of committee members won't return due to retirement, Senate races and a few election losses. Some members may choose to switch assignments once the next Congress convenes in January 2017, however
You may also be interested in...
Medical Innovation Bills On Fast Track In Congress, But Some Barriers Remain
With an all-Republican House, Senate and administration lined up to lead the government following the 2016 elections, the path is clear for passage of a set of FDA reforms to ease device approvals embedded in a combined House 'Cures' and Senate medical innovation package. It could even happen over the upcoming lame-duck session, before the new administration and Congress take over. But controversy around price-gouging by drug firms still could stymie quick Cures bill passage, an industry attorney predicts. Meanwhile, medtech industry groups plan to seize on the Trump victory as a means to achieve permanent device tax repeal.
Sun Denied Over US Antitrust Challenge
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz Executive Kellum Admits US Price-Fixing
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: